Abstract 14626: Pulmonary Hypertension and Right Heart Failure as Determinants of In-Hospital Morbidity and Mortality Following Mitral Transcatheter Edge-to-Edge Repair: A Population-Based Study of 29,770 Hospitalizations
Abstract
Background: Pulmonary hypertension (PulHTN) and right heart failure (RHF) are prevalent comorbidities among patients undergoing mitral transcatheter edge-to-edge repair (M-TEER), but their impact on in-hospital outcomes remains unclear. Methods: Adult hospitalizations involving M-TEER were identified from the National Inpatient Sample (2016-2023). Patients with PulHTN and/or RHF were compared against a control group of M-TEER patients without PulHTN, RHF, or any congestive heart failure. Survey-weighted multivariable logistic regression was used to assess adjusted in-hospital outcomes. The primary outcome was in-hospital mortality. Secondary outcomes included cardiac, renal, respiratory, vascular, neurologic, and pericardial complications. A secondary analysis further stratified the patient group into PulHTN alone, PulHTN with RHF, and RHF alone to examine the differential impact of each subgroup on in-hospital mortality. Results: Among 29,770 M-TEER hospitalizations, 22,155 (74.4%) had PulHTN and/or RHF, with a significantly higher comorbidity burden across cardiovascular, metabolic, and renal domains (Charlson index 3.44 vs. 1.32, p<0.001)(Table 1a). After adjustment, PulHTN and/or RHF was associated with significantly higher odds of in-hospital mortality, cardiogenic shock, cardiac arrest, cardiac dysrhythmias, cardiac tamponade, pericardial effusion, acute kidney injury, mechanical ventilation, and pleural effusion(Table 1b).On secondary analysis, the majority of the patient group had PulHTN alone (92.96%), followed by PulHTN with RHF (3.90%) and RHF alone (3.14%). In-hospital mortality was highest among those with concomitant PulHTN and RHF (6.9%), compared to RHF alone (5.0%) and PulHTN alone (2.5%). On adjusted analysis, concomitant PulHTN and RHF carried significantly higher mortality compared to PulHTN alone (aOR 2.38, 95% CI 1.183-4.772, p=0.015), whereas isolated RHF did not reach statistical significance (aOR 1.79, 95% CI 0.780-4.097, p=0.170). Conclusions: Pulmonary hypertension and/or right heart failure identify a high-risk population among patients undergoing M-TEER, and are associated with significantly increased in-hospital mortality, hemodynamic instability, pericardial complications, acute kidney injury, and need for mechanical ventilation. The co-existence of PulHTN and RHF conferred the highest mortality risk, suggesting that right ventricular decompensation may be a key determinant of adverse outcomes in this population.